$6.5B revenue (2024), Muttenz-headquartered specialty chemicals producer expanded Texas site for GMP-certified polyethylene glycol excipients. Expansion targets growing pharmaceutical formulation demand as contract manufacturers scale capacity.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.